Promising new pancreatic cancer treatment moves forward

by Huntsman Cancer InstituteCredit: CC0 Public DomainEven among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progres

Updated on: May 07,2024

Promising new pancreatic cancer treatment moves forward

by Huntsman Cancer InstituteCredit: CC0 Public DomainEven among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progres

Updated on:May 07,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on: March 01,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on:March 01,2024

Genetic testing for prostate cancer increases after introduction of point-of-care program

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainSome patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing progr

Updated on: January 02,2024

Genetic testing for prostate cancer increases after introduction of point-of-care program

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainSome patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing progr

Updated on:January 02,2024

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Updated on: February 03,2024

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Updated on:February 03,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on: September 27,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on:September 27,2024

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli

Updated on: February 18,2024

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli

Updated on:February 18,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on: February 03,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on:February 03,2024

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on: April 09,2024

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on:April 09,2024

Increasingly under fire as potential health hazards, gas stoves could be banned in 2023

by Nara SchoenbergCredit: Pixabay/CC0 Public DomainCiting studies that link gas stoves to health problems, including asthma in children, a U.S. Consumer Product Safety Commission official said his age

Updated on: January 30,2024

Increasingly under fire as potential health hazards, gas stoves could be banned in 2023

by Nara SchoenbergCredit: Pixabay/CC0 Public DomainCiting studies that link gas stoves to health problems, including asthma in children, a U.S. Consumer Product Safety Commission official said his age

Updated on:January 30,2024

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by

Updated on: January 23,2024

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by

Updated on:January 23,2024

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024